This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FEI's CEO Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript)

FEI Company (FEIC)

Bank of America Merrill Lynch 2012 Health Care Conference Transcript

May 17, 2012 11:40 AM ET


Don Kania – President and CEO


Derik de Bruin – Bank of America Merrill Lynch


Derik de Bruin – Bank of America Merrill Lynch

Yeah, final day of the Bank of America Merrill Lynch 2012 Health Care Conference. I‘m Derik de Bruin, the Life Sciences Tools and Diagnostics Analyst, and it’s my pleasure this morning to introduce next company, FEI Company, with President and CEO, Don Kania speaking today. There will be a brief presentation followed by some Q&A.

With that, Don.

Don Kania

Thanks a lot and it’s a pleasure to be here. So, get going to the, obviously, the Safe Harbor statement on the slide. We are not going to give anything new in terms of guidance or anything like that. Well, we’ll be reaffirming any guidance, but we’ll show it.

So, who is FEI? I think, we’re, just knew this space and it’s the healthcare world. Our company makes electron microscopes and similar nano tools. There is really three core technologies that we have, one is called transmission electron microscopy, the scanning electron microscopes, and this we called focused ion beam.

All you need to do is we make instrumentation that can see atoms, image molecules in three dimensions, and can -- with the machine surfaces at the atomic scale. And we configure three basic technologies to deliver that capability through a variety of markets, that’s how we do, average selling price, just over $1 million to give you a sense.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs